Ogawa K - Search Results

1

Astatine-211-labeled aza-vesamicol derivatives as sigma receptor ligands for targeted alpha therapy.

Ogawa K, Nishizawa K, Washiyama K, Munekane M, Fuchigami T, Echigo H, Mishiro K, Hirata S, Wakabayashi H, Takahashi K, Kinuya S. Ogawa K, et al. Nucl Med Biol. 2023 Jul-Aug;122-123:108369. doi: 10.1016/j.nucmedbio.2023.108369. Epub 2023 Jul 22. Nucl Med Biol. 2023. PMID: 37516066

2

A simple and rapid radiochemical choline acetyltransferase (ChAT) assay screening test.

Shiba K, Ogawa K, Kinuya S, Yajima K, Mori H. Shiba K, et al. Among authors: ogawa k. J Neurosci Methods. 2006 Oct 15;157(1):98-102. doi: 10.1016/j.jneumeth.2006.04.004. Epub 2006 May 12. J Neurosci Methods. 2006. PMID: 16698086

3

Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.

Hanaoka H, Mukai T, Tamamura H, Mori T, Ishino S, Ogawa K, Iida Y, Doi R, Fujii N, Saji H. Hanaoka H, et al. Among authors: ogawa k. Nucl Med Biol. 2006 May;33(4):489-94. doi: 10.1016/j.nucmedbio.2006.01.006. Epub 2006 May 2. Nucl Med Biol. 2006. PMID: 16720240

4

Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.

Ogawa K, Mukai T, Asano D, Kawashima H, Kinuya S, Shiba K, Hashimoto K, Mori H, Saji H. Ogawa K, et al. J Nucl Med. 2007 Jan;48(1):122-7. J Nucl Med. 2007. PMID: 17204708 Free article.

5

In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.

Akhter N, Shiba K, Ogawa K, Kinuya S, Nakajima K, Mori H. Akhter N, et al. Among authors: ogawa k. Nucl Med Biol. 2007 Aug;34(6):697-702. doi: 10.1016/j.nucmedbio.2007.05.005. Nucl Med Biol. 2007. PMID: 17707810

6

A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl)piperidino]cyclohexanol [(+)-pIV] as a ligand for sigma receptor imaging.

Akhter N, Shiba K, Ogawa K, Tsuji S, Kinuya S, Nakajima K, Mori H. Akhter N, et al. Among authors: ogawa k. Nucl Med Biol. 2008 Jan;35(1):29-34. doi: 10.1016/j.nucmedbio.2007.09.005. Nucl Med Biol. 2008. PMID: 18158940

7

alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.

Yoshimoto M, Ogawa K, Washiyama K, Shikano N, Mori H, Amano R, Kawai K. Yoshimoto M, et al. Among authors: ogawa k. Int J Cancer. 2008 Aug 1;123(3):709-15. doi: 10.1002/ijc.23575. Int J Cancer. 2008. PMID: 18498129

8

Potential usefulness of D2R reporter gene imaging by IBF as gene therapy monitoring for cerebellar neurodegenerative diseases.

Shiba K, Torashima T, Hirai H, Ogawa K, Akhter N, Nakajima K, Kinuya S, Mori H. Shiba K, et al. Among authors: ogawa k. J Cereb Blood Flow Metab. 2009 Feb;29(2):434-40. doi: 10.1038/jcbfm.2008.137. Epub 2008 Nov 12. J Cereb Blood Flow Metab. 2009. PMID: 19002197

9

Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases.

Ogawa K, Kawashima H, Shiba K, Washiyama K, Yoshimoto M, Kiyono Y, Ueda M, Mori H, Saji H. Ogawa K, et al. Nucl Med Biol. 2009 Feb;36(2):129-35. doi: 10.1016/j.nucmedbio.2008.11.007. Nucl Med Biol. 2009. PMID: 19217524

10

Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy.

Ogawa K, Shiba K, Akhter N, Yoshimoto M, Washiyama K, Kinuya S, Kawai K, Mori H. Ogawa K, et al. Cancer Sci. 2009 Nov;100(11):2188-92. doi: 10.1111/j.1349-7006.2009.01279.x. Epub 2009 Jul 10. Cancer Sci. 2009. PMID: 19659515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,696 results

Search Page

Filters